Production (Stage)
Tevogen Bio Holdings Inc.
TVGN
$1.31
$0.086.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.55% | 162.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.61% | 53.86% | |||
| Operating Income | -10.61% | -53.86% | |||
| Income Before Tax | -9.77% | -60.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.77% | -60.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.77% | -60.51% | |||
| EBIT | -10.61% | -53.86% | |||
| EBITDA | -10.65% | -54.22% | |||
| EPS Basic | 26.19% | -154.18% | |||
| Normalized Basic EPS | 27.49% | -156.02% | |||
| EPS Diluted | 20.63% | -154.18% | |||
| Normalized Diluted EPS | 27.49% | -156.02% | |||
| Average Basic Shares Outstanding | 51.29% | -37.31% | |||
| Average Diluted Shares Outstanding | 51.29% | -37.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||